The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
First-Trimester or Second-Trimester Screening, or Both, for Down's Syndrome
Open accessAbstract
BACKGROUND: It is uncertain how best to screen pregnant women for the presence of fetal Down's syndrome: to perform first-trimester screening, to perform second-trimester screening, or to use strategies incorporating measurements in both trimesters. METHODS: Women with singleton pregnancies underwent first-trimester combined screening (measurement of nuchal translucency, pregnancy-associated plasma protein A [PAPP-A], and the free beta subunit of human chorionic gonadotropin at 10 weeks 3 days through 13 weeks 6 days of gestation) and second-trimester quadruple screening (measurement of alpha-fetoprotein, total human chorionic gonadotropin, unconjugated estriol, and inhibin A at 15 through 18 weeks of gestation). We compared the results of stepwise sequential screening (risk results provided after each test), fully integrated screening (single risk result provided), and serum integrated screening (identical to fully integrated screening, but without nuchal translucency). RESULTS: First-trimester screening was performed in 38,167 patients; 117 had a fetus with Down's syndrome. At a 5 percent false positive rate, the rates of detection of Down's syndrome were as follows: with first-trimester combined screening, 87 percent, 85 percent, and 82 percent for measurements performed at 11, 12, and 13 weeks, respectively; with second-trimester quadruple screening, 81 percent; with stepwise sequential screening, 95 percent; with serum integrated screening, 88 percent; and with fully integrated screening with first-trimester measurements performed at 11 weeks, 96 percent. Paired comparisons found significant differences between the tests, except for the comparison between serum integrated screening and combined screening. CONCLUSIONS: First-trimester combined screening at 11 weeks of gestation is better than second-trimester quadruple screening but at 13 weeks has results similar to second-trimester quadruple screening. Both stepwise sequential screening and fully integrated screening have high rates of detection of Down's syndrome, with low false positive rates.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Snijders, R., Noble, P., Sebire, N., Souka, A., & Nicolaides, K. (1998) · The Lancet · doi:10.1016/s0140-6736(97)11280-6 · Cited by 1,572
Egger, M., Jüni, P., Bartlett, C., Holenstein, F., & Sterne, J. (2003) · Health Technology Assessment · doi:10.3310/hta7010 · Cited by 1,181
Nicolaides, K. H., Azar, G., Byrne, D., Mansur, C., & Marks, K. (1992) · BMJ · doi:10.1136/bmj.304.6831.867 · Cited by 1,056
Wald, N. J., Rodeck, C., Hackshaw, A. K., Walters, J., Chitty, L., & Mackinson, A. M. (2003) · Health Technology Assessment · doi:10.3310/hta7110 · Cited by 585
Self-citationFirst-Trimester Screening for Trisomies 21 and 18
Wapner, R., Thom, E., Simpson, J. L., Pergament, E., Silver, R., Filkins, K., Platt, L., Mahoney, M., Johnson, A., Hogge, W. A., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa025273 · Cited by 563
Wald, N. J., Watt, H. C., & Hackshaw, A. K. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908123410701 · Cited by 530
Self-citationHadlock, F. P., Shah, Y. P., Kanon, D. J., & Lindsey, J. V. (1992) · Radiology · doi:10.1148/radiology.182.2.1732970 · Cited by 457
Antenatal Screening for Down's Syndrome
Wald, N. J., Kennard, A., Hackshaw, A., & McGuire, A. (1997) · Journal of Medical Screening · doi:10.1177/096914139700400402 · Cited by 406
Self-citationRevised estimates of the maternal age specific live birth prevalence of Down's syndrome
Morris, J. K., Mutton, D. E., & Alberman, E. (2002) · Journal of Medical Screening · doi:10.1136/jms.9.1.2 · Cited by 327
Lowering blood pressure to prevent myocardial infarction and stroke: a new preventive strategy
Law, M., Wald, N., & Morris, J. (2003) · Health Technology Assessment · doi:10.3310/hta7310 · Cited by 327
Self-citationFirst-Trimester Sonographic Screening for Down Syndrome*1
Malone, F. D. (2003) · Obstetrics and Gynecology · doi:10.1016/j.obstetgynecol.2003.08.004 · Cited by 130
Self-citationWright, D., Bradbury, I., BENN, P. A., Cuckle, H., & Ritchie, K. (2004) · Prenatal Diagnosis · doi:10.1002/pd.974 · Cited by 118
EGAN, J. F. X., Kaminsky, L. M., DeRoche, M. E., Barsoom, M. J., Borgida, A., & BENN, P. A. (2002) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2002.126980 · Cited by 63
First-Trimester Screening for Trisomies 21 and 18
Wapner, R. J., Thom, E. A., Simpson, J. L., Pergament, E., Silver, R. K., Filkins, K. A., Platt, L. D., Mahoney, M., Johnson, A., Hogge, W. A., et al. (2004) · Obstetrical & Gynecological Survey · doi:10.1097/01.ogx.0000115850.05556.bc · Cited by 42
Research works printed but not linked: 5
- 10.1002/(SICI)1097-0223(199709)17:9<821::AID-PD154>3.0.CO;2-5 · doi:10.1002/(sici)1097-0223(199709)17:9<821::aid-pd154>3.0.co;2-5
- Wald N, Hackshaw A. Tests using multiple markers. In: Wald N, Leck I, eds. Antenatal and neonatal screening. 2nd ed. Oxford, England: Oxford University Press, 2000:23-57. · doi:10.1093/acprof:oso/9780192628268.003.0002
- 10.1136/jms.7.2.74 · doi:10.1136/jms.7.2.74
- 10.1097/01.AOG.0000173318.54978.1f · doi:10.1097/01.aog.0000173318.54978.1f
- 10.1002/pd.840 · doi:10.1002/pd.840
Cited by
Health Supervision for Children With Down Syndrome
Bull, M. J., & the Committee on Genetics (2011) · Pediatrics · doi:10.1542/peds.2011-1605 · Cited by 1,231
Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood
Fan, H. C., Blumenfeld, Y. J., Chitkara, U., Hudgins, L., & Quake, S. R. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0808319105 · Cited by 1,114
Chiu, R. W. K., Chan, K. C. A., Gao, Y., Lau, V. Y. M., Zheng, W., Leung, T. Y., Foo, C. H. F., Xie, B., Tsui, N. B. Y., Lun, F. M. F., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810641105 · Cited by 942
Palomaki, G. E., Kloza, E. M., Lambert-Messerlian, G. M., Haddow, J. E., Neveux, L. M., Ehrich, M., van den Boom, D., Bombard, A. T., Deciu, C., Grody, W. W., et al. (2011) · Genetics in Medicine · doi:10.1097/gim.0b013e3182368a0e · Cited by 939
Self-citationCell-free DNA Analysis for Noninvasive Examination of Trisomy
Norton, M. E., Jacobsson, B., Swamy, G. K., Laurent, L. C., Ranzini, A. C., Brar, H., Tomlinson, M. W., Pereira, L., Spitz, J. L., Hollemon, D., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1407349 · Cited by 817
Metadata
- Authors
- Malone, F. D., Canick, J. A., Ball, R. H., Nyberg, D. A., Comstock, C. H., Bukowski, R., Berkowitz, R. L., Gross, S. J., Dugoff, L., Craigo, S. D., Timor-Tritsch, I. E., Carr, S. R., Wolfe, H. M., Dukes, K., Bianchi, D. W., Rudnicka, A. R., Hackshaw, A. K., Lambert-Messerlian, G., Wald, N. J., & D'Alton, M. E.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2005-11-10
- Volume
- 353
- Issue
- 19
- Pages
- 2001-2011
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2117315526
- Cited by
- 1,081
- References
- 14
- FWCI
- 57.63
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.